UCHL1 and COVID-19: When compared to the same healthy controls (n = 60), across all timepoints, both COVID-19 subgroups (COVID and neuro-COVID) showed increased levels of NfL, GFAP, and tTau (but not UCH-L1 (Fig. 1g–j, Supplementary Table 1)).